PHPIX ProFunds Pharmaceuticals UltraSector Inv Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Merck & Co (NYSE:MRK), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI).

The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests in financial instruments that the fund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the pharmaceuticals segment of the S&P Total Market Index, which comprises the following sub-industry: pharmaceuticals. The fund is non-diversified.

The average market capitalization across the ProFunds Pharmaceuticals UltraSector Inv MF is 54.27B. The market cap for tickers in the group ranges from 4.46B to 331.75B. MRK holds the highest valuation in this group at 331.75B. The lowest valued company is AXSM at 4.46B.

The average weekly volume growth across all stocks in the ProFunds Pharmaceuticals UltraSector Inv MF was 5%. For the same stocks of the MF, the average monthly volume growth was 14% and the average quarterly volume growth was 156%